Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

This study is currently recruiting participants.

Verified January 2013 by Kuopio University Hospital

Sponsor:

Information provided by (Responsible Party):

Sari Hamalainen, Kuopio University Hospital

ClinicalTrials.gov Identifier:

NCT00781040

First received: October 27, 2008

Last updated: January 24, 2013

Last verified: January 2013

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	December 2014 (Final data collection date for primary outcome measure)

No publications provided by Kuopio University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Vänskä M, Koivula I, Hämäläinen S, Pulkki K, Nousiainen T, Jantunen E, Juutilainen A. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematologica. 2011 Sep;96(9):1385-9.

To Top